查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1482392

生物材料市场：依产品类型、最终用户、地区 - 全球产业分析、规模、占有率、成长、趋势、预测，2024-2032 年

Biomaterials Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究彻底分析了生物材料市场，并提供了详细介绍其全球前景的综合报告。 这份详细的出版物提供了有关市场动态、趋势、机会和课题的宝贵见解，并对其结构进行了全面概述。 在独特的数据和统计数据的支持下，本研究预测了 2024 年至 2032 年生物材料市场的预期成长轨迹。

2024年，全球生物材料市场价值1468.3亿美元。 预计到 2032 年将激增至 4,700 亿美元，2024 年至 2032 年复合年增长率为 14.5%。

关键见解

  • 生物材料市场规模（2024 年）：1,468.3 亿美元
  • 预测市场规模（2032 年）：4,700 亿美元
  • 全球市场成长率（复合年增长率，2024-2032 年）：14.5%

生物材料市场 - 报告范围：

生物材料是各种医疗应用的基本组成部分，包括植入物、义肢、组织工程、药物传递系统和再生医学。 该市场面向医疗保健产业、研究机构和学术中心，提供各种生物材料，包括金属、陶瓷、聚合物和复合材料。

市场成长是由慢性病盛行率上升、人口老化、材料科学技术进步以及对微创外科手术需求不断增加等因素所推动的。 此外，生物材料在骨科、心血管外科、牙科和眼科手术中的不断扩大的应用正在推动市场扩张，并促进生物材料製造商、医疗器材製造商和医疗保健提供者之间的合作。

推动市场成长的因素：

医疗植入物的需求不断增加：骨科、心血管和牙科疾病的日益流行正在增加对基于生物材料的医疗植入物（例如人工关节、支架、牙科植入物和起搏器）的需求，这增加了需求并支持市场成长。

技术创新：生物材料合成、表面改质技术和积层製造技术的进步使得生物相容性、生物可吸收性和功能性生物材料的开发成为可能，从而改善植入物的性能和患者的治疗效果。

在再生医学中的应用：生物材料在组织工程、干细胞治疗、器官移植等方面发挥着重要作用，促进组织再生、伤口癒合和功能恢復，拓展了再生医学和细胞治疗领域的市场。扩展。

市场限制因素：

生物相容性和免疫原性：植入物与宿主的相互作用、异物反应和长期生物降解特性因生物材料的类型和应用而异；确保安全仍然是一个课题。

监管合规性：生物材料分类、安全评估和临床测试方面的监管障碍给製造商带来了合规负担，并影响了上市障碍、产品开发时间表和商业化策略。

成本和承受能力：生物材料製造、品质控制流程和监管批准的成本高昂，特别是在新兴市场，使用先进生物材料进行治疗的医疗预算和报销范围有限，这对广泛使用造成了经济障碍。

市场机会：

个人化医疗：个人化医疗和精准医疗模式的出现正在促进患者特异性生物材料、客製化植入物和能够适应临床变异的标靶药物输送系统的开发。

多功能生物材料：将生物材料与生物活性分子、生长因子和治疗剂结合，可生产多功能植入物、智慧型装置和控释製剂，以提高治疗效果和降低医疗成本。

生物製造技术：3D生物列印、组织工程和晶片器官平台的进步促进了复杂仿生结构、血管组织和类器官的创建，以加速药物发现、疾病建模和个人化再生治疗。

本报告解决的关键问题

  • 推动全球生物材料市场成长的关键因素有哪些？
  • 哪些类型和应用的生物材料正在推动各个医疗保健领域的市场推广？
  • 技术进步如何改变生物材料市场的竞争格局？
  • 谁是生物材料市场的主要参与者？
  • 全球生物材料市场的新趋势和未来前景是什么？

竞争资讯与业务策略：

全球生物材料市场的领先公司正在专注于创新、产品差异化和策略合作伙伴关係，以获得竞争优势。 这些公司投资于研发，开发先进的生物材料配方、製造流程和生物医学设备，以满足各种临床需求和治疗应用。 与医疗保健提供者、学术机构和监管机构的合作伙伴关係促进市场进入和技术采用，促进市场成长和扩张。

主要公司简介

  • Evonik Industries AG
  • Medtronic plc
  • Carpenter Technology Corporation
  • Invibio Ltd.
  • Berkeley Advanced Biomaterials
  • BASF SE
  • Zimmer Biomet Holdings, Inc.
  • Stryker
  • Covalon Technologies Ltd.
  • Johnson & Johnson

生物材料产业研究细分

依材质

  • 金属生物材料
  • 陶瓷生物材料
  • 高分子生物材料
  • 天然生物材料

依目的

  • 牙科
  • 心血管
  • 骨科
  • 伤口癒合
  • 神经病学
  • 手术

依地区

  • 北美
  • 拉丁美洲
  • 欧洲
  • 南亚
  • 东亚
  • 大洋洲
  • 中东/非洲

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 价值链分析
  • 波特五力分析
  • 杵分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 经济概况
  • 法规和认证

第三章宏观经济与预测因子

  • 世界经济成长展望
  • GDP 成长前景
  • 依行业划分的世界成长前景
  • 其他宏观经济因素

第 4 章 2024-2032 年全球生物材料市场展望

  • 全球生物材料市场前景：依材料种类、数量、价值划分，2024-2032 年
    • 主要亮点
      • 金属生物材料
      • 陶瓷生物材料
      • 高分子生物材料
      • 天然生物材料
  • 全球生物材料市场前景：依应用、数量、价值划分，2024-2032 年
    • 主要亮点
      • 牙科
      • 心血管
      • 骨科
      • 伤口癒合
      • 神经病学
      • 手术
  • 全球生物材料市场展望：地区、数量、价值，2024-2032 年
    • 主要亮点
      • 北美
      • 欧洲
      • 东亚
      • 南亚/大洋洲
      • 拉丁美洲
      • 中东/非洲

第五章北美生物材料市场展望，2024-2032

第 6 章欧洲生物材料市场展望，2024-2032

第 7 章南亚/大洋洲生物材料市场前景，2024-2032

第 8 章东亚生物材料市场展望，2024-2032

第 9 章拉丁美洲生物材料市场前景，2024-2032

第 10 章 2024-2032 年中东及非洲生物材料市场前景

第十一章竞争态势

  • 材料类型与应用热图
  • 製造商与材料类型热图
  • 2023 年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • Evonik Industries AG
    • Medtronic plc
    • Carpenter Technology Corporation
    • Invibio Ltd.
    • Berkeley Advanced Biomaterials
    • BASF SE
    • Covestro AG
    • Celanese Corporation
    • Zimmer Biomet Holdings, Inc.
    • Stryker
    • Covalon Technologies Ltd.
    • Johnson & Johnson
    • DSM Netherlands
    • Corbion NV
    • Victrex Plc
    • Mitsubishi Chemical Group Corporation

第12章附录

  • 调查方法
  • 报告先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP2781

Persistence Market Research has conducted a thorough analysis of the Biomaterials Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Biomaterials Market spanning from 2024 to 2032.

In 2024, the global biomaterials market reached a valuation of US$ 146.83 billion. By 2032, it is projected to soar to US$ 470 billion, experiencing a substantial CAGR of 14.5% from 2024 to 2032.

Key Insights:

  • Biomaterials Market Size (2024): US$ 146.83 billion
  • Projected Market Value (2032): US$ 470 billion
  • Global Market Growth Rate (CAGR 2024-2032): 14.5%

Biomaterials Market - Report Scope:

Biomaterials serve as fundamental components in various medical applications, including implants, prosthetics, tissue engineering, drug delivery systems, and regenerative medicine. The market caters to healthcare industries, research institutions, and academic centers, offering a diverse range of biomaterial types, including metals, ceramics, polymers, and composites.

Market growth is propelled by factors such as increasing prevalence of chronic diseases, aging population, technological advancements in material science, and growing demand for minimally invasive surgical procedures. Moreover, the expanding application of biomaterials in orthopedics, cardiovascular, dental, and ophthalmic surgeries fosters market expansion, driving collaborations between biomaterial manufacturers, medical device companies, and healthcare providers.

Market Growth Drivers:

Rising Demand for Medical Implants: The growing prevalence of orthopedic disorders, cardiovascular diseases, and dental conditions drives the demand for biomaterial-based medical implants, including joint replacements, stents, dental implants, and pacemakers, supporting market growth.

Technological Innovations: Advances in biomaterial synthesis, surface modification techniques, and additive manufacturing technologies enable the development of biocompatible, bioresorbable, and functional biomaterials, enhancing implant performance and patient outcomes.

Regenerative Medicine Applications: Biomaterials play a critical role in tissue engineering, stem cell therapy, and organ transplantation, facilitating tissue regeneration, wound healing, and functional restoration, driving market expansion in regenerative medicine and cell therapy fields.

Market Restraints:

Biocompatibility and Immunogenicity: Ensuring biomaterial biocompatibility, bioactivity, and immunological safety remains a challenge, as implant-host interactions, foreign body responses, and long-term biodegradation properties vary among different biomaterial types and applications.

Regulatory Compliance: Regulatory hurdles related to biomaterial classification, safety assessment, and clinical testing impose compliance burdens on manufacturers, affecting market entry barriers, product development timelines, and commercialization strategies.

Cost and Affordability: The high cost of biomaterial manufacturing, quality control processes, and regulatory approvals pose economic barriers to widespread adoption, particularly in emerging markets with limited healthcare budgets and reimbursement coverage for advanced biomaterial-based therapies.

Market Opportunities:

Personalized Medicine: The advent of personalized medicine and precision healthcare models promotes the development of patient-specific biomaterials, customized implants, and targeted drug delivery systems, addressing individual genetic, physiological, and clinical variability.

Multifunctional Biomaterials: Integration of biomaterials with bioactive molecules, growth factors, and therapeutic agents enables the fabrication of multifunctional implants, smart devices, and controlled-release formulations, enhancing therapeutic efficacy and reducing healthcare costs.

Biofabrication Technologies: Advancements in 3D bioprinting, tissue engineering, and organ-on-a-chip platforms facilitate the fabrication of complex biomimetic structures, vascularized tissues, and organoids, accelerating drug discovery, disease modeling, and personalized regenerative therapies.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global biomaterials market?
  • Which biomaterial types and applications are driving market adoption across different healthcare sectors?
  • How are technological advancements reshaping the competitive landscape of the biomaterials market?
  • Who are the key players contributing to the biomaterials market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global biomaterials market?

Competitive Intelligence and Business Strategy:

Leading players in the global biomaterials market focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced biomaterial formulations, manufacturing processes, and biomedical devices, catering to diverse clinical needs and therapeutic applications. Collaborations with healthcare providers, academic institutions, and regulatory agencies facilitate market access and technology adoption, driving market growth and expansion.

Key Companies Profiled

  • Evonik Industries AG
  • Medtronic plc
  • Carpenter Technology Corporation
  • Invibio Ltd.
  • Berkeley Advanced Biomaterials
  • BASF SE
  • Zimmer Biomet Holdings, Inc.
  • Stryker
  • Covalon Technologies Ltd.
  • Johnson & Johnson

Biomaterials Industry Research Segmentation

By Material:

  • Metallic Biomaterials
  • Ceramic Biomaterials
  • Polymeric Biomaterials
  • Natural Biomaterials

By Application:

  • Dental
  • Cardiovascular
  • Orthopedic
  • Wound Healing
  • Neurology
  • Surgery

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa"

Table of Contents

1. Executive Summary

  • 1.1. Global Biomaterials Market Snapshot, 2023 and 2031
  • 1.2. Market Opportunity Assessment, 2024-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. PESTLE Analysis
  • 2.6. COVID-19 Impact Analysis
  • 2.7. Economic Overview
  • 2.8. Regulations and Certifications

3. Macro-economic and Forecast Factors

  • 3.1. Global Economic Growth Outlook
  • 3.2. GDP Growth Outlook
  • 3.3. Global Sectoral Growth Outlook
  • 3.4. Other Macroeconomic Factors

4. Global Biomaterials Market Outlook, 2024-2032

  • 4.1. Global Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Metallic Biomaterials
      • 4.1.1.2. Ceramic Biomaterials
      • 4.1.1.3. Polymeric Biomaterials
      • 4.1.1.4. Natural Biomaterials
  • 4.2. Global Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dental
      • 4.2.1.2. Cardiovascular
      • 4.2.1.3. Orthopaedic
      • 4.2.1.4. Wound Healing
      • 4.2.1.5. Neurology
      • 4.2.1.6. Surgery
  • 4.3. Global Biomaterials Market Outlook, by Region, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. North America
      • 4.3.1.2. Europe
      • 4.3.1.3. East Asia
      • 4.3.1.4. South Asia & Oceania
      • 4.3.1.5. Latin America
      • 4.3.1.6. Middle East & Africa

5. North America Biomaterials Market Outlook, 2024-2032

  • 5.1. North America Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Metallic Biomaterials
      • 5.1.1.2. Ceramic Biomaterials
      • 5.1.1.3. Polymeric Biomaterials
      • 5.1.1.4. Natural Biomaterials
  • 5.2. North America Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dental
      • 5.2.1.2. Cardiovascular
      • 5.2.1.3. Orthopaedic
      • 5.2.1.4. Wound Healing
      • 5.2.1.5. Neurology
      • 5.2.1.6. Surgery
  • 5.3. North America Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Biomaterials Market Outlook, 2024-2032

  • 6.1. Europe Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Metallic Biomaterials
      • 6.1.1.2. Ceramic Biomaterials
      • 6.1.1.3. Polymeric Biomaterials
      • 6.1.1.4. Natural Biomaterials
  • 6.2. Europe Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dental
      • 6.2.1.2. Cardiovascular
      • 6.2.1.3. Orthopaedic
      • 6.2.1.4. Wound Healing
      • 6.2.1.5. Neurology
      • 6.2.1.6. Surgery
  • 6.3. Europe Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Germany
      • 6.3.1.2. Italy
      • 6.3.1.3. France
      • 6.3.1.4. U.K.
      • 6.3.1.5. Spain
      • 6.3.1.6. Russia
      • 6.3.1.7. Rest of Europe
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. South Asia & Oceania Biomaterials Market Outlook, 2024-2032

  • 7.1. South Asia & Oceania Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Metallic Biomaterials
      • 7.1.1.2. Ceramic Biomaterials
      • 7.1.1.3. Polymeric Biomaterials
      • 7.1.1.4. Natural Biomaterials
  • 7.2. South Asia & Oceania Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dental
      • 7.2.1.2. Cardiovascular
      • 7.2.1.3. Orthopaedic
      • 7.2.1.4. Wound Healing
      • 7.2.1.5. Neurology
      • 7.2.1.6. Surgery
  • 7.3. South Asia & Oceania Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. India
      • 7.3.1.2. Southeast
      • 7.3.1.3. ANZ
      • 7.3.1.4. Rest of South Asia & Oceania
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. East Asia Biomaterials Market Outlook, 2024-2032

  • 8.1. East Asia Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Metallic Biomaterials
      • 8.1.1.2. Ceramic Biomaterials
      • 8.1.1.3. Polymeric Biomaterials
      • 8.1.1.4. Natural Biomaterials
  • 8.2. East Asia Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dental
      • 8.2.1.2. Cardiovascular
      • 8.2.1.3. Orthopaedic
      • 8.2.1.4. Wound Healing
      • 8.2.1.5. Neurology
      • 8.2.1.6. Surgery
  • 8.3. East Asia Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. China
      • 8.3.1.2. Japan
      • 8.3.1.3. South Korea
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Biomaterials Market Outlook, 2024-2032

  • 9.1. Latin America Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Metallic Biomaterials
      • 9.1.1.2. Ceramic Biomaterials
      • 9.1.1.3. Polymeric Biomaterials
      • 9.1.1.4. Natural Biomaterials
  • 9.2. Latin America Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Dental
      • 9.2.1.2. Cardiovascular
      • 9.2.1.3. Orthopaedic
      • 9.2.1.4. Wound Healing
      • 9.2.1.5. Neurology
      • 9.2.1.6. Surgery
  • 9.3. Latin America Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Brazil
      • 9.3.1.2. Mexico
      • 9.3.1.3. Rest of Latin America
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Biomaterials Market Outlook, 2024-2032

  • 10.1. Middle East & Africa Biomaterials Market Outlook, by Material Type, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 10.1.1. Key Highlights
      • 10.1.1.1. Metallic Biomaterials
      • 10.1.1.2. Ceramic Biomaterials
      • 10.1.1.3. Polymeric Biomaterials
      • 10.1.1.4. Natural Biomaterials
  • 10.2. Middle East & Africa Biomaterials Market Outlook, by Application, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 10.2.1. Key Highlights
      • 10.2.1.1. Dental
      • 10.2.1.2. Cardiovascular
      • 10.2.1.3. Orthopaedic
      • 10.2.1.4. Wound Healing
      • 10.2.1.5. Neurology
      • 10.2.1.6. Surgery
  • 10.3. Middle East & Africa Biomaterials Market Outlook, by Country, Volume (Tons) and Value (US$ Mn), 2024-2032
    • 10.3.1. Key Highlights
      • 10.3.1.1. GCC
      • 10.3.1.2. South Africa
      • 10.3.1.3. Turkiye
      • 10.3.1.4. Rest of Middle East and Africa

11. Competitive Landscape

  • 11.1. Material Type vs Application Heatmap
  • 11.2. Manufacturer vs Material Type Heatmap
  • 11.3. Company Market Share Analysis, 2023
  • 11.4. Competitive Dashboard
  • 11.5. Company Profiles
    • 11.5.1. Evonik Industries AG
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Product Portfolio
      • 11.5.1.3. Financial Overview
      • 11.5.1.4. Business Strategies and Development
    • 11.5.2. Medtronic plc
    • 11.5.3. Carpenter Technology Corporation
    • 11.5.4. Invibio Ltd.
    • 11.5.5. Berkeley Advanced Biomaterials
    • 11.5.6. BASF SE
    • 11.5.7. Covestro AG
    • 11.5.8. Celanese Corporation
    • 11.5.9. Zimmer Biomet Holdings, Inc.
    • 11.5.10. Stryker
    • 11.5.11. Covalon Technologies Ltd.
    • 11.5.12. Johnson & Johnson
    • 11.5.13. DSM Netherlands
    • 11.5.14. Corbion NV
    • 11.5.15. Victrex Plc
    • 11.5.16. Mitsubishi Chemical Group Corporation

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations